Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03382977
Title Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors VBI Vaccines Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Irvine RECRUITING Irvine California 92868 United States Details
University of California, San Diego RECRUITING La Jolla California 92093 United States Details
University of California, Los Angeles Neuro-Oncology Program RECRUITING Los Angeles California 90095 United States Details
Stanford RECRUITING Stanford California 94305 United States Details
Miami Cancer Institute RECRUITING Miami Florida 33176 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
The Valley Hospital - Neurosurgeons of New Jersey RECRUITING Ridgewood New Jersey 07450 United States Details
The Neurological Institute of New York Columbia University Medical Center RECRUITING New York New York 10032 United States Details
Vanderbilt University Medical Center RECRUITING Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Providence - Swedish Medical Center RECRUITING Seattle Washington 98122 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field